EPOCH PHARMACEUTICALS INC
10QSB, EX-27.1, 2000-08-14
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: EPOCH PHARMACEUTICALS INC, 10QSB, 2000-08-14
Next: NATIONS GOVERNMENT INCOME TERM TRUST 2003 INC, DEF 14A, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                      18,036,078
<SECURITIES>                                         0
<RECEIVABLES>                                   41,452
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            18,238,725
<PP&E>                                         691,784
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              20,127,048
<CURRENT-LIABILITIES>                          995,474
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       248,596
<OTHER-SE>                                  17,593,220
<TOTAL-LIABILITY-AND-EQUITY>                20,127,048
<SALES>                                              0
<TOTAL-REVENUES>                               239,090
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             3,007,245
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 153
<INCOME-PRETAX>                            (2,367,332)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (2,367,332)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (2,367,332)
<EPS-BASIC>                                     (0.10)
<EPS-DILUTED>                                   (0.10)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission